166 related articles for article (PubMed ID: 11437939)
1. Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi.
Hussein MR; Sun M; Tuthill RJ; Roggero E; Monti JA; Sudilovsky EC; Wood GS; Sudilovsky O
J Cutan Pathol; 2001 Aug; 28(7):343-50. PubMed ID: 11437939
[TBL] [Abstract][Full Text] [Related]
2. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
[TBL] [Abstract][Full Text] [Related]
3. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas.
Hussein MR; Roggero E; Sudilovsky EC; Tuthill RJ; Wood GS; Sudilovsky O
Am J Dermatopathol; 2001 Aug; 23(4):308-14. PubMed ID: 11481522
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus.
Rübben A; Bogdan I; Grussendorf-Conen EI; Burg G; Böni R
Recent Results Cancer Res; 2002; 160():100-10. PubMed ID: 12079204
[TBL] [Abstract][Full Text] [Related]
5. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma.
Birindelli S; Tragni G; Bartoli C; Ranzani GN; Rilke F; Pierotti MA; Pilotti S
Int J Cancer; 2000 Apr; 86(2):255-61. PubMed ID: 10738254
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas.
Hussein MR; Haemel AK; Albert DM; Wood GS
Arch Ophthalmol; 2005 Dec; 123(12):1705-11. PubMed ID: 16344443
[TBL] [Abstract][Full Text] [Related]
7. Melanomas, dysplastic nevi and benign nevi: is dysplastic nevus a non-benign neoplasm?
Yus ES; Simon RS
J Cutan Pathol; 2002 Oct; 29(9):570; author reply 570-1. PubMed ID: 12358817
[No Abstract] [Full Text] [Related]
8. Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas.
Hussein MR; Sun M; Roggero E; Sudilovsky EC; Tuthill RJ; Wood GS; Sudilovsky O
Mol Carcinog; 2002 May; 34(1):35-44. PubMed ID: 12112321
[TBL] [Abstract][Full Text] [Related]
9. Molecular aspects of melanocytic dysplastic nevi.
Hussein MR; Wood GS
J Mol Diagn; 2002 May; 4(2):71-80. PubMed ID: 11986397
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma.
Uribe P; Wistuba II; Solar A; Balestrini C; Perez-Cotapos ML; Gonzalez S
Am J Dermatopathol; 2005 Aug; 27(4):279-85. PubMed ID: 16121045
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
12. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
[TBL] [Abstract][Full Text] [Related]
13. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J
J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117
[TBL] [Abstract][Full Text] [Related]
14. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
Goldstein AM; Dracopoli NC; Engelstein M; Fraser MC; Clark WH; Tucker MA
Am J Hum Genet; 1994 Mar; 54(3):489-96. PubMed ID: 8116618
[TBL] [Abstract][Full Text] [Related]
15. Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas.
Uribe P; Wistuba II; Gonzalez S
Am J Dermatopathol; 2009 Jun; 31(4):354-63. PubMed ID: 19461239
[TBL] [Abstract][Full Text] [Related]
16. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Goldin LR; Dracopoli NC; Clark WH; Tucker MA
Am J Hum Genet; 1996 May; 58(5):1050-6. PubMed ID: 8651266
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG
Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions.
Singh RS; Diwan AH; Zhang PS; Prieto VG
J Cutan Pathol; 2007 Mar; 34(3):220-5. PubMed ID: 17302605
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
20. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
Albert LS; Rhodes AR; Sober AJ
J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
